Spdr Ser Tr S&p Biotech Put Option
(XBI)
|
8.2 |
$66M |
|
700k |
94.89 |
Teva Pharmaceutical Inds Sponsored Ads Call Option
(TEVA)
|
5.3 |
$43M |
|
3.1M |
14.11 |
Moderna Put Option
(MRNA)
|
5.3 |
$43M |
|
400k |
106.56 |
Apogee Therapeutics
(APGE)
|
4.9 |
$39M |
|
592k |
66.45 |
Xenon Pharmaceuticals
(XENE)
|
4.5 |
$36M |
|
837k |
43.05 |
Madrigal Pharmaceuticals
(MDGL)
|
3.8 |
$31M |
|
115k |
267.04 |
Crinetics Pharmaceuticals In
(CRNX)
|
2.7 |
$22M |
|
470k |
46.81 |
Autolus Therapeutics Spon Ads
(AUTL)
|
2.7 |
$22M |
|
3.4M |
6.38 |
Celldex Therapeutics Com New
(CLDX)
|
2.6 |
$21M |
|
510k |
41.97 |
Arcellx Common Stock
(ACLX)
|
2.6 |
$21M |
|
300k |
69.55 |
Vera Therapeutics Cl A
(VERA)
|
2.5 |
$20M |
|
470k |
43.12 |
Inozyme Pharma
(INZY)
|
2.5 |
$20M |
|
2.6M |
7.66 |
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
2.3 |
$18M |
|
17M |
1.08 |
Kura Oncology
(KURA)
|
1.9 |
$16M |
|
731k |
21.33 |
Spyre Therapeutics Com New
(SYRE)
|
1.9 |
$16M |
|
410k |
37.93 |
Immunovant
(IMVT)
|
1.7 |
$14M |
|
429k |
32.31 |
Verona Pharma Sponsored Ads
(VRNA)
|
1.6 |
$13M |
|
818k |
16.09 |
Beigene Sponsored Adr
(BGNE)
|
1.6 |
$13M |
|
82k |
156.39 |
Cerevel Therapeutics Hldng I
(CERE)
|
1.6 |
$13M |
|
300k |
42.27 |
Nurix Therapeutics
(NRIX)
|
1.5 |
$12M |
|
810k |
14.70 |
Astria Therapeutics
(ATXS)
|
1.5 |
$12M |
|
846k |
14.07 |
Nuvalent Inc-a
(NUVL)
|
1.4 |
$11M |
|
150k |
75.09 |
Axsome Therapeutics
(AXSM)
|
1.4 |
$11M |
|
140k |
79.80 |
Establishment Labs Holdings Ord
(ESTA)
|
1.4 |
$11M |
|
215k |
50.90 |
Apellis Pharmaceuticals
(APLS)
|
1.2 |
$9.7M |
|
165k |
58.78 |
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
|
1.2 |
$9.4M |
|
10M |
0.94 |
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
1.2 |
$9.4M |
|
831k |
11.30 |
Bridgebio Pharma Call Option
(BBIO)
|
1.1 |
$9.3M |
|
300k |
30.92 |
Ironwood Pharmaceuticals Com Cl A Call Option
(IRWD)
|
1.1 |
$9.0M |
|
1.0M |
8.71 |
Compass Pathways Sponsored Ads
(CMPS)
|
1.1 |
$8.6M |
|
1.0M |
8.32 |
Inari Medical Ord
(NARI)
|
1.0 |
$8.4M |
|
175k |
47.98 |
Geron Corporation
(GERN)
|
1.0 |
$8.3M |
|
2.5M |
3.30 |
Morphic Hldg
(MORF)
|
1.0 |
$7.9M |
|
225k |
35.20 |
Fulcrum Therapeutics
(FULC)
|
1.0 |
$7.8M |
|
825k |
9.44 |
Omeros Corp Note 5.250% 2/1 (Principal)
|
0.9 |
$7.6M |
|
11M |
0.73 |
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.8 |
$6.8M |
|
286k |
23.65 |
Elevation Oncology
(ELEV)
|
0.8 |
$6.5M |
|
1.3M |
5.13 |
Gritstone Oncology Ord Put Option
(GRTS)
|
0.8 |
$6.1M |
|
2.4M |
2.57 |
IsoRay
|
0.8 |
$6.1M |
|
5.1M |
1.19 |
Alnylam Pharmaceuticals Call Option
(ALNY)
|
0.7 |
$6.0M |
|
40k |
149.45 |
Absci Corp
(ABSI)
|
0.7 |
$5.8M |
|
1.0M |
5.68 |
Coherus Biosciences Note 1.500% 4/1 (Principal)
|
0.7 |
$5.8M |
|
9.0M |
0.64 |
Savara
(SVRA)
|
0.7 |
$5.7M |
|
1.2M |
4.98 |
Rapt Therapeutics Put Option
(RAPT)
|
0.7 |
$5.7M |
|
637k |
8.98 |
Cytokinetics Com New
(CYTK)
|
0.7 |
$5.6M |
|
80k |
70.11 |
Vaxcyte
(PCVX)
|
0.7 |
$5.5M |
|
80k |
68.31 |
Roivant Sciences SHS
(ROIV)
|
0.7 |
$5.3M |
|
500k |
10.54 |
Guardant Health Call Option
(GH)
|
0.6 |
$5.2M |
|
250k |
20.63 |
Springworks Therapeutics
(SWTX)
|
0.6 |
$4.9M |
|
100k |
49.22 |
Krystal Biotech
(KRYS)
|
0.6 |
$4.8M |
|
27k |
177.93 |
Mersana Therapeutics
(MRSN)
|
0.6 |
$4.5M |
|
1.0M |
4.48 |
Crispr Therapeutics Namen Akt Call Option
(CRSP)
|
0.5 |
$4.4M |
|
65k |
68.16 |
Cullinan Oncology
(CGEM)
|
0.5 |
$4.4M |
|
259k |
17.04 |
Mineralys Therapeutics
(MLYS)
|
0.5 |
$4.2M |
|
328k |
12.91 |
Viking Therapeutics
(VKTX)
|
0.5 |
$4.1M |
|
50k |
82.00 |
Rezolute Com New
(RZLT)
|
0.5 |
$4.1M |
|
1.6M |
2.55 |
Mirum Pharmaceuticals
(MIRM)
|
0.5 |
$4.0M |
|
160k |
25.12 |
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
0.5 |
$3.8M |
|
75k |
50.23 |
Immatics SHS
(IMTX)
|
0.5 |
$3.7M |
|
350k |
10.51 |
Intra Cellular Therapies
(ITCI)
|
0.4 |
$3.5M |
|
50k |
69.20 |
Arrowhead Pharmaceuticals
(ARWR)
|
0.4 |
$3.4M |
|
120k |
28.60 |
Immunitybio Put Option
(IBRX)
|
0.4 |
$3.2M |
|
589k |
5.37 |
Nextcure
(NXTC)
|
0.4 |
$3.0M |
|
1.4M |
2.23 |
Terns Pharmaceuticals
(TERN)
|
0.4 |
$3.0M |
|
450k |
6.56 |
Protagonist Therapeutics
(PTGX)
|
0.4 |
$2.9M |
|
100k |
28.93 |
Helix Acquisition Corp Ii Cl A Ord Shs
(HLXB)
|
0.3 |
$2.6M |
|
250k |
10.35 |
Regenxbio Inc equity us cm
(RGNX)
|
0.3 |
$2.3M |
|
110k |
21.07 |
Newamsterdam Pharma Company W Exp 11/22/202
(NAMSW)
|
0.3 |
$2.2M |
|
203k |
11.04 |
Alkermes SHS
(ALKS)
|
0.3 |
$2.0M |
|
75k |
27.07 |
Akero Therapeutics Call Option
(AKRO)
|
0.2 |
$1.9M |
|
75k |
25.26 |
Wave Life Sciences SHS
(WVE)
|
0.2 |
$1.8M |
|
287k |
6.17 |
Boston Scientific Corporation
(BSX)
|
0.2 |
$1.7M |
|
25k |
68.49 |
Kezar Life Sciences
(KZR)
|
0.2 |
$1.6M |
|
1.8M |
0.90 |
Arya Sciences Acqu Corp Iv Cl A
(ARYD)
|
0.2 |
$1.5M |
|
134k |
11.27 |
Tango Therapeutics
(TNGX)
|
0.1 |
$1.2M |
|
150k |
7.94 |
Zura Bio Class A Ord Shs
(ZURA)
|
0.1 |
$1.2M |
|
450k |
2.57 |
Tourmaline Bio
(TRML)
|
0.1 |
$1.1M |
|
50k |
22.90 |
Travere Therapeutics
(TVTX)
|
0.1 |
$964k |
|
125k |
7.71 |
Avrobio Ord
(AVRO)
|
0.1 |
$896k |
|
700k |
1.28 |
Annovis Bio Put Option
(ANVS)
|
0.1 |
$868k |
|
73k |
11.90 |
Promis Neurosciences Com New
(PMN)
|
0.1 |
$508k |
|
266k |
1.91 |
Immatics W Exp 07/01/202
(IMTXW)
|
0.1 |
$487k |
|
187k |
2.60 |
Q32 Bio
(QTTB)
|
0.1 |
$473k |
|
28k |
17.04 |
Context Therapeutics
(CNTX)
|
0.1 |
$454k |
|
329k |
1.38 |
Glycomimetics Put Option
(GLYC)
|
0.1 |
$427k |
|
142k |
3.00 |
Passage Bio
(PASG)
|
0.0 |
$357k |
|
264k |
1.35 |
Avalo Therapeutics Com New
(AVTX)
|
0.0 |
$218k |
|
10k |
21.75 |
Cassava Sciences W Exp 11/15/202
|
0.0 |
$98k |
|
24k |
4.03 |
Rocket Pharmaceuticals W Exp 09/02/202
(RCKTW)
|
0.0 |
$22k |
|
75k |
0.30 |